Marine Drugs (Jun 2024)

Cytotoxic Pentaketide-Sesquiterpenes from the Marine-Derived Fungus <i>Talaromyces variabilis</i> M22734

  • Lingzhi Tang,
  • Jinmei Xia,
  • Zhongwei Chen,
  • Xiaohui Wu,
  • Guangyu Li,
  • Qiliang Lai,
  • Zongze Shao,
  • Weiyi Wang,
  • Xuan Hong

DOI
https://doi.org/10.3390/md22060274
Journal volume & issue
Vol. 22, no. 6
p. 274

Abstract

Read online

Talaromyces, a filamentous fungus widely distributed across terrestrial and marine environments, can produce a diverse array of natural products, including alkaloids, polyketones, and polyketide-terpenoids. Among these, chrodrimanins represented a typical class of natural products. In this study, we isolated three previously undescribed pentaketide-sesquiterpenes, 8,9-epi-chrodrimanins (1–3), along with eight known compounds (4–11). The structures of compounds 1–3 were elucidated using nuclear magnetic resonance (NMR) and mass spectrometry (MS), while their absolute configurations were determined through X-ray crystallography and electronic circular dichroism (ECD) computations. The biosynthetic pathways of compounds 1–3 initiate with 6-hydroxymellein and involve multiple stages of isoprenylation, cyclization, oxidation, and acetylation. We selected four strains of gastrointestinal cancer cells for activity evaluation. We found that compound 3 selectively inhibited MKN-45, whereas compounds 1 and 2 exhibited no significant inhibitory activity against the four cell lines. These findings suggested that 8,9-epi-chrodrimanins could serve as scaffold compounds for further structural modifications, potentially leading to the development of targeted therapies for gastric cancer.

Keywords